Corticotropin-releasing factor promotes growth of brain norepinephrine neuronal processes through Rho GTPase regulators of the actin cytoskeleton in rat

European Journal of Neuroscience

Volumn 24, Issue 9, 2006, Pages 2481-2490

  Swinny, Jerome D ^a,b   Valentino, Rita J ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Astressin; Locus coeruleus; MAPK; Protein kinase A; Protein kinase C; Urocortin 2

Indexed keywords

ACTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE; NORADRENALIN; PEPTIDE; RAC1 PROTEIN; RHO FACTOR; RHO GUANOSINE TRIPHOSPHATASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL STRUCTURE; CONTROLLED STUDY; CYTOSKELETON; EMOTIONAL STRESS; FEMALE; HORMONAL REGULATION; HORMONE STRUCTURE; INHIBITION KINETICS; LIMBIC SYSTEM; LOCUS CERULEUS; MICROTUBULE; MODEL; MOLECULAR BIOLOGY; NERVE CELL GROWTH; NERVE CELL PLASTICITY; NERVE GROWTH; NEUROMODULATION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT;

ACTINS; ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CORTICOTROPIN-RELEASING HORMONE; CYTOSKELETON; FEMALE; IMMUNOHISTOCHEMISTRY; LOCUS COERULEUS; MALE; NEURONAL PLASTICITY; NEURONS; NOREPINEPHRINE; ORGAN CULTURE TECHNIQUES; RATS; RHO GTP-BINDING PROTEINS;

EID: 33750958716     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.05129.x     Document Type: Article

References (59)

1. Alessi, D.R., Cuenda, A., Cohen, P., Dudley, D.T. & Saltiel, A.R. (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem., 270, 27489-27494.
2. Aston-Jones, G., Ennis, M., Pieribone, V.A., Nickell, W.T. & Shipley, M.T. (1986) The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network. Science, 234, 734-737.
3. Aston-Jones, G., Rajkowski, J. & Cohen, J. (2000) Locus coeruleus and regulation of behavioral flexibility and attention. Prog. Brain Res., 126, 165-182.
4. Aston-Jones, G., Shipley, M.T. & Grzanna, R. (1995) The locus coeruleus, A5 and A7 noradrenergic cell groups. In Paxinos, G. (Ed.), The Rat Brain. Academic Press, New York, pp. 183-213.
5. Barandier, C., Ming, X.F., Rusconi, S. & Yang, Z. (2003) PKC is required for activation of ROCK by RhoA in human endothelial cells. Biochem. Biophys. Res. Commun., 304, 714-719.
6. Berridge, C.W. & Waterhouse, B.D. (2003) The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res. Brain Res. Rev., 42, 33-84.
7. Brar, B.K., Chen, A., Perrin, M.H. & Vale, W. (2004) Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides. Endocrinology, 145, 1718-1729.
8. Chalmers, D.T., Lovenberg, T.W., Grigoriadis, D.E., Behan, D.P. & De Souza, E.B. (1996) Corticotropin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci., 17, 166-172.
9. Chang, C.P., Pearse, R.V., 2nd, O'Connell, S. & Rosenfeld, M.G. (1993) Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron, 11, 1187-1195.
10. Chen, Y. Bender, R.A. Brunson, K.L. Pomper, J.K. Grigoriadis, D.E. Wurst, W. & Baram, T.Z. (2004) Modulation of dendritic differentiation by corticotropin-releasing factor in the developing hippocampus. Proc. Natl Acad. Sci. USA, 101, 15782-15787.
11. Cibelli, G. Corsi, P. Diana, G. Vitiello, F. & Thiel, G. (2001) Corticotropin-releasing factor triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways. Eur. J. Neurosci., 13, 1339-1348.
12. Clough, R.W. Peterson, B.R. Steenbergen, J.L. Jobe, P.C. Eells, J.B. Browning, R.A. & Mishra, P.K. (1998) Neurite extension of developing noradrenergic neurons is impaired in genetically epilepsy-prone rats (GEPR-3s): an in vitro study on the locus coeruleus. Epilepsy Res., 29, 135-146.
13. Dautzenberg, F.M. & Hauger, R.L. (2002) The CRF peptide family and their receptors: yet more partners discovered. Trends Pharmacol. Sci., 23, 71-77.
14. Dong, J.M. Leung, T. Manser, E. & Lim, L. (1998) cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKalpha. J. Biol. Chem., 273, 22554-22562.
15. Gao, Y. Dickerson, J.B. Guo, F. Zheng, J. & Zheng, Y. (2004) Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl Acad. Sci. USA, 101, 7618-7623.
16. Grammatopoulos, D.K. Randeva, H.S. Levine, M.A. Kanellopoulou, K.A. & Hillhouse, E.W. (2001) Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins. J. Neurochem., 76, 509-519.
17. Grammatopoulos, D.K. Randeva, H.S. Levine, M.A. Katsanou, E.S. & Hillhouse, E.W. (2000) Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins. Mol. Endocrinol., 14, 2076-2091.
18. Guthrie, K.M. Tran, A. & Baratta, J., Yu, J. & Robertson, R.T. (2005) Patterns of afferent projections to the dentate gyrus studied in organotypic co-cultures. Brain Res. Dev. Brain Res., 157, 162-171.
19. Hendelman, W.J. Marshall, K.C. Ferguson, R. & Carriere, S. (1982) Catecholamine neurons of the central nervous system in organotypic culture. Dev. Neurosci., 5, 64-76.
20. Imaki, T. Nahan, J.L. Sawachenko, P.E. & Vale, W. (1991) Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J. Neurosci., 11, 585-599.
21. Imaki, T. Vale, W. & Sawchenko, P.E. (1992) Regulation of corticotropin-releasing hormone mRNA in neuroendocrine and autonomic neurons by osmotic stimuli and volume loading. Neuroendocrinology, 56, 633-640.
22. Kase, H. Iwahashi, K. Nakanishi, S. Matsuda, Y. Yamada, K. Takahashi, M. Murakata, C. Sato, A. & Kaneko, M. (1987) K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. Biochem. Biophys. Res. Commun., 142, 436-440.
23. Kuwahara, K. Saito, Y. Nakagawa, O. Kishimoto, I. Harada, M. Ogawa, E. Miyamoto, Y. Hamanaka, I. Kajiyama, N. Takahashi, N. Izumi, T. Kawakami, R. Tamura, N. Ogawa, Y. & Nakao, K. (1999) The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytes - possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy. FEBS Lett., 452, 314-318.
24. Lang, P. Gesbert, F. Delespine-Carmagnat, M. Stancou, R. Pouchelet, M. & Bertoglio, J. (1996) Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J., 15, 510-519.
25. Lovenberg, T.W. Liaw, C.W. Grigoriadis, D.E. Clevenger, W. Chalmers, D.T. De Souza, E.B. & Oltersdorf, T. (1995) Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl Acad. Sci. USA, 92, 836-840.
26. McEwen, B.S. (2001) Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann. NY Acad. Sci., 933, 265-277.
27. Mehta, D. Rahman, A. & Malik, A.B. (2001) Protein kinase C-alpha signals rho-guanine nucleotide dissociation inhibitor phosphorylation and rho activation and regulates the endothelial cell barrier function. J. Biol. Chem., 276, 22614-22620.
28. Metzger, F. & Kapfhammer, J.P. (2000) Protein kinase C activity modulates dendritic differentiation of rat Purkinje cells in cerebellar slice cultures. Eur. J. Neurosci., 12, 1993-2005.
29. Nakayama, A.Y. Harms, M.B. & Luo, L. (2000) Small GTPases Rac and Rho in the maintenance of dendritic spines and branches in hippocampal pyramidal neurons. J. Neurosci., 20, 5329-5338.
30. Nonaka, T. Araki, M. Kimura, H. Nagatsu, I. Satoh, F. & Masuzawa, T. (1993) The capacity of central and peripheral catecholaminergic neurons to innervate the pineal organ and cerebral cortex of the rat: in vitro immunohistochemical observations. Cell Tissue Res., 273, 525-531.
31. O'Connor, K.L. & Mercurio, A.M. (2001) Protein kinase A regulates Rac and is required for the growth factor-stimulated migration of carcinoma cells. J. Biol. Chem., 276, 47895-47900.
32. Okuyama, S. Chaki, S. & Kawashima, N. (1999) Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin- releasing facotr subtype 1 receptor antagonists CRA 1000 and CRA1001. J. Pharmacol. Exp. Ther., 289, 926-935.
33. Owens, M.J. & Nemeroff, C.B. (1991) Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev., 43, 425-474.
34. Page, M.E. Berridge, C.W. Foote, S.L. & Valentino, R.J. (1993) Corticotropin-releasing factor in the locus coeruleus mediates EEG activation associated with hypotensive stress. Neurosci. Lett., 164, 81-84.
35. Papadopoulou, N. Chen, J. Randeva, H.S. Levine, M.A. Hillhouse, E.W. & Grammatopoulos, D.K. (2004) Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity. Mol. Endocrinol., 18, 624-639.
36. Perrin, M.H. Sutton, S.W. Cervini, L.A. Rivier, J.E. & Vale, W.W. (1999) Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. J. Pharmacol. Exp. Ther., 288, 729-734.
37. Plotsky, P.M. Thrivikraman, K.V. Nemeroff, C.B. Caldji, C. Sharma, S. & Meaney, M.J. (2005) Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring. Neuropsychopharmacology, 30, 2192-2204.
38. Popovik, E. & Haynes, L.W. (2000) Survival and mitogenesis of neuroepithelial cells are influenced by noradrenergic but not cholinergic innervation in cultured embryonic rat neopallium. Brain Res., 853, 227-235.
39. Reyes, T.M. Lewis, K. Perrin, M.H. Kunitake, K.S. Vaughan, J. Arias, C.A. Hogenesch, J.B. Gulyas, J. Rivier, J. Vale, W.W. & Sawchenko, P.E. (2001) Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc. Natl Acad. Sci. USA, 98, 2843-2848.
40. Reyes, B.A.S. Valentino, R.J. Xu, G. & Van Bockstaele, E.J. (2005) Hypothalamic projections to locus coeruleus neurons in rat brain. Eur. J. Neurosci., 22, 93-106.
41. Ruchhoeft, M.L. Ohnuma, S. McNeill, L. Holt, C.E. & Harris, W.A. (1999) The neuronal architecture of Xenopus retinal ganglion cells is sculpted by rho-family GTPases in vivo. J. Neurosci., 19, 8454-8463.
42. Ruhmann, A. Bonck, I. Lin, C.R. Rosenfeld, M.G. & Speiss, J. (1998) Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2-selective antisauvagine-30. Proc. Natl Acad. Sci. USA, 95, 15264-15269.
43. Rusnak, M. & Gainer, H. (2005) Differential effects of forskolin on tyrosine hydroxylase gene transcription in identified brainstem catecholaminergic neuronal subtypes in organotypic culture. Eur. J. Neurosci., 21, 889-898.
44. Sapolsky, R.M. (2000) Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry, 57, 925-935.
45. Schulz, D.W. Mansbach, R.S. Sprouse, J. Braselton, J.P. Collins, J. Corman, M. Dunaiskis, A. Faraci, S. Schmidt, A.W. Seeger, T. Seymour, P. Tingley, F.D.I. Winston, E.N. Chen, Y.L. & Heym, J. (1996) CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors. Proc. Natl Acad. Sci. USA, 93, 10477-10482.
46. Shipley, M.T. Fu, L. Ennis, M. Liu, W. & Aston-Jones, G. (1996) Dendrites of locus coeruleus neurons extend preferentially into two pericoerulear zones. J. Comp. Neurol., 365, 56-68.
47. Swanson, L.W. & Hartman, B.K. (1976) The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat using dopamine-B-hydroxylase as a marker. J. Comp. Neurol., 163, 467-506.
48. Swinny, J.D. Metzger, F.J.I.J.-P. Gounko, N.V. Gramsbergen, A. & van der Want, J.J. (2004) Corticotropin-releasing factor and urocortin differentially modulate rat Purkinje cell dendritic outgrowth and differentiation in vitro. Eur. J. Neurosci., 19, 1749-1758.
49. Toullec, D. Pianetti, P. Coste, H. Bellevergue, P. Grand-Perret, T. Ajakane, M. Baudet, V. Boissin, P. Boursier, E. Loriolle, F.& et al. (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem., 266, 15771-15781.
50. Traver, S., Marien, M., Martin, E., Hirsch, E.C. & Michel, P.P. (2006) The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neutrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway. Mol. Pharmacol., 70, 30-40.
51. Vale, W., Spiess, J., Rivier, C. & Rivier, J. (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science, 213, 1394-1397.
52. Valentino, R.J., Chen, S., Zhu, Y. & Aston-Jones, G. (1996) Evidence for divergent projections of corticotropin-releasing hormone neurons of Barrington's nucleus to the locus coeruleus and spinal cord. Brain Res., 732, 1-15.
53. Valentino, R.J., Page, M.E. & Curtis, A.L. (1991) Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res., 555, 25-34.
54. Valentino, R.J. & Van Bockstaele, E.J. (2005) Functional interactions between stress neuromediators and the locus coeruleus-noradrenaline system. In Steckler, T. & Kalin, N. (Eds), Handbook of Stress and the Brain. Elsevier, The Netherlands, pp. 465-486.
55. Van Aelst, L. & Cline, H.T. (2004) Rho GTPases and activity-dependent dendrite development. Curr. Opin. Neurobiol., 14, 297-304.
56. Van Bockstaele, E.J., Bajic, D., Proudfit, H. & Valentino, R.J. (2001) Topographic architecture of stress-related pathways targeting the noradrenergic locus coeruleus. Physiol. Behav., 73, 273-283.
57. Van Bockstaele, E.J., Colago, E.E.O. & Valentino, R.J. (1998) Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the coordination of emotional and cognitive limbs of the stress response. J. Neuroendocrinol., 10, 743-757.
58. Victorov, I., Nguyen-Legros, J., Boutry, J.M., Alvarez, C. & Hauw, J.J. (1979) The early outgrowth of catecholaminergic fibers and the development of the nucleus of the locus coeruleus in tissue culture of newborn mice in Leighton tubes. Biomedicine, 30, 161-168.
59. Wietfeld, D., Heinrich, N., Furkert, J., Fechner, K., Beyermann, M., Bienert, M. & Berger, H. (2004) Regulation of the coupling to different G proteins of rat corticotropin-releasing factor receptor type 1 in human embryonic kidney 293 cells. J. Biol. Chem., 279, 38386-38394.